In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Undertreatment and overtreatment should be avoided (see aspirin synthroid - Pediatric Use). Call your doctor for medical advice about side effects.
synthroid sweety hands
Antidiabetic Agents - Biguanides - Meglitinides - Sulfonylureas - Thiazolidinediones - Insulin Addition of levothyroxine to antidiabetic or insulin therapy may result in increased antidiabetic agent or insulin requirements. Dosage adjustment may be needed . Proper Use of Synthroid Dosing The dose of this medicine will be different for different patients. --If you miss a dose... Important safety information: Some brands of Synthroid may cause choking, gagging, or trouble swallowing. Call your doctor for medical advice about side effects. In addition, thyroid hormones and thyroid status have varied effects on the pharmacokinetics and actions of other drugs. Failure to do so may precipitate an acute adrenal crisis when thyroid hormone therapy is initiated, due to increased metabolic clearance of glucocorticoids by thyroid hormone. In patients with secondary (pituitary) aspirin synthroid tertiary (hypothalamic) hypothyroidism, the levothyroxine sodium dose should be titrated until the patient is clinically euthyroid and the serum free- T4 level is restored to the upper half of the normal range. Patients with coronary artery disease who are receiving levothyroxine therapy should be monitored closely during surgical procedures, since the possibility of precipitating cardiac arrhythmias may be greater in those treated with levothyroxine. The liver is the major site of degradation for both T4 and T3, with T4 deiodination also occurring at a number of additional sites, including the kidney and other tissues. Plasmapheresis, charcoal hemoperfusion and exchange transfusion have been reserved for cases in which continued clinical deterioration occurs despite conventional therapy. Talk with your doctor about how this could affect you. More frequent intervals of monitoring may be necessary if poor compliance is suspected or abnormal values are obtained. How should I take Synthroid? Take Synthroid exactly as prescribed by your doctor. No COMMON side effects have been reported with the use of Synthroid . Partial hair loss may occur rarely during the first few months of Synthroid therapy, but this is usually temporary. Synthroid tablets should be protected from light and moisture. 1 Product Characteristics Color BROWN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;125 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7068-13 100 TABLET In 1 BOTTLE None 2 0074-7068-71 28 TABLET In 1 BOX None 3 aspirin synthroid 1000 TABLET In 1 BOTTLE None 4 0074-7068-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7068-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End aspirin synthroid NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information aspirin synthroid Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-3727 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 137 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO. Copyright 1996-2010 Cerner Multum, Inc.
However, aspirin synthroid T4 levels are usually normal but may occasionally be slightly increased. Synthroid is used for: Treating low thyroid hormone levels and certain types of goiters. Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). 6 Product aspirin synthroid Color ORANGE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;25 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4341-13 100 TABLET In 1 BOTTLE None 2 0074-4341-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-4552 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 50 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC Product Characteristics Color WHITE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;50 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-4552-13 100 TABLET In 1 BOTTLE None 2 0074-4552-19 1000 TABLET In 1 BOTTLE None 3 0074-4552-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 3 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-4552-11) 4 0074-4552-71 28 TABLET In 1 BOX None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets aspirin synthroid Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-5182 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 75 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C RED NO. For this medicine, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Synthroid side effects Side effects from Synthroid, other than overdose symptoms, are rare. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Undertreatment and overtreatment should be avoided (see PRECAUTIONS - Pediatric Use). In patients with secondary (pituitary) or tertiary (hypothalamic) hypothyroidism, the levothyroxine sodium dose should aspirin synthroid titrated until the patient is clinically euthyroid and the serum aspirin synthroid T4 level is restored to the upper half of the normal range. Long-term aminoglutethimide therapy may minimally decrease T4 and T3 levels and increase TSH, although all values remain within normal limits in most patients.